why choose us

First received: September 23, 2025

Clinical Trial: Study of DM-101PX in Adults With Birch Pollen Allergy

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Birch Pollen Allergy

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Randomized, Double-Blind, Placebo-controlled Study to Investigate the Safety and Efficacy in Reducing Nasal Allergen Challenge Provoked Symptoms of Treatment With DM-101PX in Adults With Bi

Brief Summary: Randomized, double-blind placebo-controlled phase 2 trial with the aim to investigate safety and efficacy of DM-101-PX in reducing allergic symptoms provoked by nasal allergen challenge in birch pollen allergic adults. Expanded access to the study treatment is not available.

Read more